These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10450041)

  • 1. Membrane compatibility and clearance of hepatitis C virus in chronic dialysis patients.
    Adorati M; Pipan C; Botta G
    Nephron; 1999; 82(4):358. PubMed ID: 10450041
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. II. Interleukin-1 production.
    Herbelin A; Ureña P; Man NK; Drüeke T; Descamps-Latscha B
    Contrib Nephrol; 1989; 74():79-85. PubMed ID: 2702150
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. I. Radiolabeled endotoxin.
    Ureña P; Herbelin A; Basile C; Zingraff J; Man NK; Drüeke T
    Contrib Nephrol; 1989; 74():71-8. PubMed ID: 2702149
    [No Abstract]   [Full Text] [Related]  

  • 4. Fate of beta-2-microglobulin during dialysis on polysulfone and AN69 membranes.
    Goldman M; Nortier J; Dhaene M; Amraoui Z; Vanherweghem JL
    Contrib Nephrol; 1989; 74():127-31. PubMed ID: 2702129
    [No Abstract]   [Full Text] [Related]  

  • 5. Highly permeable and biocompatible membranes and prevalence of dialysis-associated arthropathy.
    Kessler M; Netter P; Maheut H; Wolf C; Prenat E; Huu TC; Gaucher A
    Lancet; 1991 May; 337(8749):1092-3. PubMed ID: 1673510
    [No Abstract]   [Full Text] [Related]  

  • 6. Biocompatible membranes in acute renal failure.
    Shaldon S
    Lancet; 1996 Jan; 347(8995):205-6. PubMed ID: 8544586
    [No Abstract]   [Full Text] [Related]  

  • 7. Who really determines dialysis?
    Polaschegg HD
    ASAIO J; 1996; 42(6):1031-2. PubMed ID: 8959280
    [No Abstract]   [Full Text] [Related]  

  • 8. Eicosanoid release as an indicator of membrane biocompatibility.
    Schultze G; Wagner K; Neumayer HH; Molzahn M
    Contrib Nephrol; 1987; 59():44-50. PubMed ID: 3442987
    [No Abstract]   [Full Text] [Related]  

  • 9. The AN69ST dialysis membrane. A new approach for reducing systemic heparinization.
    Renaux JL; Atti M
    Contrib Nephrol; 2002; (137):111-9. PubMed ID: 12101943
    [No Abstract]   [Full Text] [Related]  

  • 10. [Beneficial effect of AN69 membranes on anemia in hemodialyzed patients].
    García Cortés MJ; Sánchez Perales MC; Liébana A; Gil JM; Borrego FJ; Borrego J; Pérez del Barrio P; Serrano P; Pérez Bañasco V
    Nefrologia; 2001; 21(4):370-5. PubMed ID: 11816513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using AN69 ST membrane: a dialysis centre experience.
    Maheut H; Lacour F
    Nephrol Dial Transplant; 2001 Jul; 16(7):1519-20. PubMed ID: 11427664
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients.
    Vidales-Braz BM; da Silva NM; Lobato R; Germano FN; da Mota LD; Barros EJ; de Martinez AM
    Virol J; 2015 Feb; 12():8. PubMed ID: 25644891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of beta 2-microglobulin by adsorption on dialysis membranes.
    Goldman M; Dhaene M; Vanherweghem JL
    Nephrol Dial Transplant; 1987; 2(6):576-7. PubMed ID: 3126461
    [No Abstract]   [Full Text] [Related]  

  • 14. Is hepatitis C virus RNA detectable in dialysis ultrafiltrate?
    Manzini P; Amore A; Brunetto MR; Martina G; Verme G; Bonino F; Coppo R
    Nephron; 1996; 72(1):102-3. PubMed ID: 8903872
    [No Abstract]   [Full Text] [Related]  

  • 15. AN69-ST membrane, a useful option in two cases of severe dialysis reactions.
    Cerqueira A; Martins PA; Carvalho BA; Vasconcelos MP
    Clin Nephrol; 2015 Feb; 83(2):100-3. PubMed ID: 25208312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro blood compatibility evaluation of cuprophan and polyacrylonitrile membranes.
    Stefanovic V; Vlahovic P; Kostic S; Mitić-Zlatkovic M
    Nephron; 1998; 79(3):350-1. PubMed ID: 9678440
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanisms of acute leukopenia in hemodialysis. Role of direct leukocyte and dialyzer membrane interaction].
    Pacitti A; Segoloni G; Triolo G; Tetta C; Messina M; Bussolino F; Camussi G; Ragni R; Martini PF; Coppo R; Vercellone A
    Minerva Nefrol; 1980; 27(4):651-3. PubMed ID: 7254693
    [No Abstract]   [Full Text] [Related]  

  • 18. Biofiltration: 58 months of experience.
    Cairo G; Bonforte G; Dozio B
    Int J Artif Organs; 1986 Dec; 9 Suppl 3():81-4. PubMed ID: 3557681
    [No Abstract]   [Full Text] [Related]  

  • 19. Biocompatible membranes in acute renal failure: prospective case-controlled study.
    Shaldon S
    Nephrol Dial Transplant; 1997 Jan; 12(1):235-6. PubMed ID: 9027814
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of interleukin-1 and tumor necrosis factor during in vitro hemodialysis with different membranes.
    Schindler R; Lonnemann G; Shaldon S; Koch KM; Dinarello CA
    Contrib Nephrol; 1989; 74():58-65. PubMed ID: 2702147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.